NCT04379427

Brief Summary

Measurement algorithm control and optimization with subsequent performance evaluation of Sanmina biosensors in monitoring of glucose, heart rate (HR), and SpO2 in patients with type 1 and type 2 diabetes during a standardized meal experiment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 7, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 7, 2020

Completed
Last Updated

May 7, 2020

Status Verified

April 1, 2020

Enrollment Period

8 months

First QC Date

April 29, 2020

Last Update Submit

May 4, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Performance and accuracy of glucose levels

    performance and accuracy of the Sanmina biosensors (wearable and finger clip) in monitoring glucose levels (mg/dL) during a standardized meal experiment. Measurements (during the meal experiment) of the Sanmina biosensor will be compared to the capillary blood glucose reference method YSI STAT 2300 (glucose, in mg/dL).

    approx. 240 minutes

  • Performance and accuracy of pO2

    performance and accuracy of the Sanmina biosensors (wearable and finger clip) in monitoring pO2 (%) during a standardized meal experiment. PO2-measurements (during the meal experiment) of the Sanmina biosensor will be compared to the patient monitor (%).

    approx. 240 minutes

  • Performance and accuracy of heart rate

    performance and accuracy of the Sanmina biosensors (wearable and finger clip) in monitoring heart rate (pulse/min) during a standardized meal experiment. Heart rate measurements (during the meal experiment) of the Sanmina biosensor will be compared to the patient monitor heart rate(pulse/min).

    approx. 240 minutes

Study Arms (3)

Optimization and control 1

EXPERIMENTAL

The first study part/arm includes 12 patients and will be used for optimization and control of the measurement algorithms of the Sanmina biosensors.

Device: Sanmina Biosensor

Optimization and control 2

EXPERIMENTAL

The second study part/arm includes 12 patients and will be used for optimization and control of the measurement algorithms of the Sanmina biosensors.

Device: Sanmina Biosensor

Precision and accuracy

OTHER

During the third study part with enrolment of 36 patients, the precision and accuracy of the final Sanmina biosensor algorithm will be demonstrated.

Device: Sanmina Biosensor

Interventions

non-invasive blood glucose measurement using the Sanmina Biosensor referenced with the invasive reference blood glucose device YSI 2400 Plus.

Optimization and control 1Optimization and control 2Precision and accuracy

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 or Type 2 diabetic subjects or healthy probands
  • Subjects who are able to complete informed consent form (by him/herself or by his/her guardian);
  • years old and above;
  • Anatomically suitable finger in discretion of the investigator

You may not qualify if:

  • Any conditions that may hamper good visual contact between the finger or wrist and sensor, such as raised birthmarks, scars, tattoos;
  • Pregnancy;
  • Nursing mothers;
  • Any skin scratch(es), damage, over dry, long nails on the measured finger;
  • Unsuitable finger with the device might be excluded if recognized during the trial;
  • Medication containing nitrates

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pfuetzner Science & Health Institute GmbH

Mainz, Rhineland-Palatinate, 55128, Germany

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: The first 2 study parts include 12 patients each. In the third study part 36 patients will be enrolled. Study part 1 and 2 will be used for optimization and control of the measurement algorithms of the Sanmina biosensors. During the third study part with enrolment of 36 patients, the precision and accuracy of the final Sanmina biosensor algorithm will be demonstrated.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2020

First Posted

May 7, 2020

Study Start

March 25, 2019

Primary Completion

November 7, 2019

Study Completion

April 1, 2020

Last Updated

May 7, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations